Traffic Lights - Latest Updates

Last updated: 05/09/2022

Other updates on this site
Drug Name Classification Clinical Indication Comments
TIRZEPATIDE (Mounjaro®) (UPDATED) Green Management of overweight and obesity

For managing overweight and obesity in adults in line with NICE TA1026.

March 2026: Green for eligible cohort only as per LLR weight management guide or access via LLR specialist weight loss clinic

CAPTOPRIL (NEW) Red For Acute Scleroderma renal crisis when haemodynamically unstable

Once stable to switch to longer acting ACE inhibitor

HYDRALAZINE (UPDATED) Yellow Hypertension & Heart Failure
Inbrija Yellow Indicated for the intermittent treatment of episodic motor fluctuations (OFF episodes) in adult patients with Parkinson’s disease (PD) treated with a levodopa/dopa-decarboxylase inhibitor (1)
OMEPRAZOLE DISPERSIBLE (UPDATED) Green

2nd line choice dispersible PPI

Other Updates on this Website

Recent documents from LLR APC and TAS


About the Leicester, Leicestershire and Rutland Area Prescribing Committee

In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.

Leicestershire Health Community comprises the Leicester, Leicestershire and Rutland Integrated Care Board, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more